Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Demosthenes E Ziogas"'
Autor:
Dimitrios H Roukos, Michail Mitsis, Ioannis D Kyrochristos, Evangelos G Baltagiannis, Demosthenes E Ziogas, Anna Goussia
Publikováno v:
Personalized Medicine. 17:245-250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0697e071a1f4d182e2cd904efca674
https://doi.org/10.2217/pme-2020-0056
https://doi.org/10.2217/pme-2020-0056
Autor:
Dimitrios H Roukos, Anna Goussia, Demosthenes E Ziogas, Evangelos G Baltagiannis, Ioannis D Kyrochristos, Georgios Pappas-Gogos, Michail Mitsis
Publikováno v:
Biomarkers in Medicine. 14:335-339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8daa54eb916eaa30188ac1c3354450df
https://doi.org/10.2217/bmm-2020-0025
https://doi.org/10.2217/bmm-2020-0025
Autor:
Michail Mitsis, Aikaterini Vlachioti, Persefoni Antoniou, Demosthenes E Ziogas, Dimitrios H Roukos, E. Lykoudis
Publikováno v:
Personalized Medicine. 16:361-364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e8f8e7c119054fde9a64b4ee816717
https://doi.org/10.2217/pme-2019-0036
https://doi.org/10.2217/pme-2019-0036
Publikováno v:
Future Oncology. 15:1805-1810
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c463267b846d0baebaa92ca03862875
https://doi.org/10.2217/fon-2019-0132
https://doi.org/10.2217/fon-2019-0132
Publikováno v:
Drug Discovery Today. 24:1281-1294
Progress in understanding and overcoming fatal intrinsic and acquired resistance is slow, with only a few exceptions. Despite advances in modern genome and transcriptome analysis, the controversy of the three different theories on drug resistance and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f63ef92fd0558f889fe142abf3c01b
https://doi.org/10.1016/j.drudis.2019.04.008
https://doi.org/10.1016/j.drudis.2019.04.008
Publikováno v:
Medicinal Research Reviews. 39:1205-1227
Despite remarkable progress in medium-term overall survival benefit in the adjuvant, neoadjuvant and metastatic settings, with multiple recent targeted drug approvals, acquired resistance, late relapse, and cancer-related death rates remain challengi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed5a9f3265d754fd075c5e84eb940c2
https://doi.org/10.1002/med.21549
https://doi.org/10.1002/med.21549
Autor:
Michail Mitsis, Ioannis D Kyrochristos, Dimitrios H Roukos, Persefoni Antoniou, Demosthenes E Ziogas, Efstathios G. Lykoudis
Publikováno v:
Pharmacogenomics. 19:1303-1310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f057cf6545a12d5899e5a05dc4d556
https://doi.org/10.2217/pgs-2018-0141
https://doi.org/10.2217/pgs-2018-0141
Publikováno v:
Biomarkers in Medicine. 12:1197-1201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb1b4e56f30bad23866524366b3c91f
https://doi.org/10.2217/bmm-2018-0269
https://doi.org/10.2217/bmm-2018-0269
Publikováno v:
Personalized Medicine. 15:467-470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3b690803f16a863bdb4d698428da2c
https://doi.org/10.2217/pme-2018-0079
https://doi.org/10.2217/pme-2018-0079
Autor:
Dimitrios H Roukos, Demosthenes E Ziogas, Efstathios G. Lykoudis, Ioannis D Kyrochristos, Dimitra V. Peristeri
Publikováno v:
Future Oncology. 14:1777-1780
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d89a106bfa656ccf6913637daf5858
https://doi.org/10.2217/fon-2018-0277
https://doi.org/10.2217/fon-2018-0277